| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR CACNA1D MAP9 DLG5 KIF27 EPB41L4B COBLL1 CEP290 WIPF3 DNM1L SPAG9 KIF20B MYO5C LLGL1 STARD9 ROCK1 KIFC3 PLEKHH2 CROCC UTRN PPP1R42 MTUS2 | 1.29e-05 | 1099 | 144 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD8 RGPD1 DNM1L TBC1D22B GIT2 ARHGAP6 LLGL1 RABGAP1L ERRFI1 RGPD5 | 3.58e-05 | 279 | 144 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 5.16e-05 | 2 | 144 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | tubulin binding | TPR MAP9 KIF27 CEP290 WIPF3 DNM1L KIF20B STARD9 KIFC3 PPP1R42 MTUS2 | 2.81e-04 | 428 | 144 | 11 | GO:0015631 |
| GeneOntologyBiologicalProcess | protein localization to organelle | TPR AHI1 RGPD8 NACA RGPD1 UBAP1 DNM1L CEP192 LMNB2 HUWE1 KIF20B DHX9 ESCO2 FSIP2 CACNG8 SH3GLB1 VPS13A MMGT1 CROCC STAG3 PCM1 RGPD5 | 3.85e-06 | 1091 | 139 | 22 | GO:0033365 |
| GeneOntologyBiologicalProcess | somatic cell DNA recombination | 1.93e-05 | 82 | 139 | 6 | GO:0016444 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors via germline recombination within a single locus | 1.93e-05 | 82 | 139 | 6 | GO:0002562 | |
| GeneOntologyBiologicalProcess | intracellular transport | MON2 TPR RGPD8 CEP290 COPB2 WIPF3 RGPD1 UBAP1 DNM1L SPAG9 LMNB2 ANKRD50 KIF20B MYO5C DHX9 ZFAND1 EPS15L1 CACNG8 SH3GLB1 NEMF VPS13A VAMP4 BBS12 PCM1 RGPD5 | 2.07e-05 | 1496 | 139 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors | 3.50e-05 | 91 | 139 | 6 | GO:0002200 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | TPR CACNA1D AHI1 NSD2 CEP290 KIAA0586 NACA AAK1 DNM1L CEP192 HUWE1 KIF20B ZFAND1 NPTN SH3GLB1 RABGAP1L SYCP1 CROCC VAMP4 PCM1 | 4.13e-05 | 1087 | 139 | 20 | GO:0032880 |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 4.51e-05 | 2 | 139 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | TPR CACNA1D AHI1 NSD2 CEP290 KIAA0586 NACA AAK1 DNM1L CEP192 HUWE1 KIF20B DHX9 ZFAND1 NPTN SH3GLB1 RABGAP1L SYCP1 CROCC VAMP4 PCM1 | 6.21e-05 | 1212 | 139 | 21 | GO:0060341 |
| GeneOntologyBiologicalProcess | cilium organization | SPAG1 AHI1 KIF27 CEP290 KIAA0586 TBC1D22B FSIP2 ODF2L TEKT1 CROCC BBS12 PCM1 | 9.37e-05 | 476 | 139 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | somatic recombination of immunoglobulin gene segments | 1.03e-04 | 69 | 139 | 5 | GO:0016447 | |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 TPR ASXL1 NSD2 KDM3B NAP1L4 LMNB2 HUWE1 ATAD2 JMJD1C RIF1 CBX5 SYCP1 PHF14 ATM HMGN4 HELLS | 1.13e-04 | 896 | 139 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | somatic diversification of immunoglobulins | 1.73e-04 | 77 | 139 | 5 | GO:0016445 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | TPR CACNA1D AHI1 NSD2 CEP290 KIAA0586 DNM1L CEP192 HUWE1 KIF20B ZFAND1 SH3GLB1 VAMP4 PCM1 | 1.88e-04 | 674 | 139 | 14 | GO:0070201 |
| GeneOntologyBiologicalProcess | cilium assembly | SPAG1 AHI1 KIF27 CEP290 KIAA0586 TBC1D22B FSIP2 ODF2L TEKT1 CROCC PCM1 | 2.15e-04 | 444 | 139 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | chromosome organization | TPR MAP9 CEP192 MSH3 RFC1 DHX9 ESCO2 LIG4 RIF1 YLPM1 SYCP1 PDS5A ATM STAG3 | 2.26e-04 | 686 | 139 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | organelle assembly | TPR MAP9 SPAG1 AHI1 KIF27 CEP290 KIAA0586 UBAP1 TBC1D22B CEP192 FSIP2 ODF2L SH3GLB1 STARD9 TMF1 TEKT1 ATM CROCC PCM1 | 2.31e-04 | 1138 | 139 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR MAP9 SPAG1 KIF27 CEP290 CEP192 KIF20B FSIP2 LLGL1 STARD9 VPS13A TMF1 TEKT1 ROCK1 KIFC3 CROCC BBS12 PCM1 | 2.72e-04 | 1058 | 139 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | immune system development | 2.84e-04 | 248 | 139 | 8 | GO:0002520 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.14e-04 | 20 | 139 | 3 | GO:0006607 | |
| GeneOntologyCellularComponent | centriole | 2.74e-06 | 172 | 142 | 9 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | DLG5 AHI1 CEP290 KIAA0586 SPAG9 CEP192 HMMR KIF20B DHX9 ODF2L STARD9 ROCK1 TTC39A ATM KIFC3 CROCC PPP1R42 MTUS2 PCM1 | 1.51e-05 | 919 | 142 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | AHI1 CEP290 KIAA0586 SPAG9 CEP192 HMMR KIF20B DHX9 ODF2L TTC39A ATM KIFC3 CROCC PPP1R42 MTUS2 PCM1 | 7.08e-05 | 770 | 142 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | transverse filament | 1.37e-04 | 3 | 142 | 2 | GO:0000802 | |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 1.37e-04 | 3 | 142 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | chromosomal region | 1.46e-04 | 421 | 142 | 11 | GO:0098687 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.32e-04 | 18 | 142 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | laminin-5 complex | 2.72e-04 | 4 | 142 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.21e-04 | 20 | 142 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 4.52e-04 | 5 | 142 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 9.41e-04 | 7 | 142 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.25e-03 | 8 | 142 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 1.32e-03 | 32 | 142 | 3 | GO:0005721 | |
| Domain | TPR-like_helical_dom | 5.96e-05 | 233 | 138 | 9 | IPR011990 | |
| Domain | Grip | 6.24e-05 | 11 | 138 | 3 | SM00755 | |
| Domain | GRIP | 6.24e-05 | 11 | 138 | 3 | PF01465 | |
| Domain | Ran_BP1 | 8.27e-05 | 12 | 138 | 3 | PF00638 | |
| Domain | RANBD1 | 8.27e-05 | 12 | 138 | 3 | PS50196 | |
| Domain | GRIP_dom | 8.27e-05 | 12 | 138 | 3 | IPR000237 | |
| Domain | GRIP | 8.27e-05 | 12 | 138 | 3 | PS50913 | |
| Domain | RanBD | 1.07e-04 | 13 | 138 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.07e-04 | 13 | 138 | 3 | IPR000156 | |
| Domain | TPR-contain_dom | 1.26e-04 | 150 | 138 | 7 | IPR013026 | |
| Domain | EGD2/NACA | 1.62e-04 | 3 | 138 | 2 | IPR016641 | |
| Domain | TPR_REGION | 2.27e-04 | 165 | 138 | 7 | PS50293 | |
| Domain | TPR | 2.27e-04 | 165 | 138 | 7 | PS50005 | |
| Domain | Kinesin_motor_CS | 2.34e-04 | 41 | 138 | 4 | IPR019821 | |
| Domain | - | 3.08e-04 | 44 | 138 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 3.08e-04 | 44 | 138 | 4 | PF00225 | |
| Domain | KISc | 3.08e-04 | 44 | 138 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.08e-04 | 44 | 138 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.08e-04 | 44 | 138 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.08e-04 | 44 | 138 | 4 | PS50067 | |
| Domain | UBA | 3.98e-04 | 47 | 138 | 4 | PS50030 | |
| Domain | P-loop_NTPase | DLG5 KIF27 ATAD5 DNM1L MSH3 RFC1 ATAD2 KIF20B MYO5C DHX9 ORC1 STARD9 YLPM1 TJP2 KIFC3 HELLS | 5.33e-04 | 848 | 138 | 16 | IPR027417 |
| Domain | NAC | 5.34e-04 | 5 | 138 | 2 | SM01407 | |
| Domain | TPR_1 | 5.44e-04 | 90 | 138 | 5 | IPR001440 | |
| Domain | TPR_1 | 5.44e-04 | 90 | 138 | 5 | PF00515 | |
| Domain | AAA | 5.87e-04 | 52 | 138 | 4 | PF00004 | |
| Domain | ATPase_AAA_core | 6.78e-04 | 54 | 138 | 4 | IPR003959 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 7.97e-04 | 6 | 138 | 2 | IPR002715 | |
| Domain | NAC | 7.97e-04 | 6 | 138 | 2 | PF01849 | |
| Domain | NAC_AB | 7.97e-04 | 6 | 138 | 2 | PS51151 | |
| Domain | - | 8.84e-04 | 207 | 138 | 7 | 1.25.40.10 | |
| Domain | Rab_bind | 1.11e-03 | 7 | 138 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.11e-03 | 7 | 138 | 2 | IPR032023 | |
| Domain | LAMININ_IVA | 1.47e-03 | 8 | 138 | 2 | PS51115 | |
| Domain | Laminin_B | 1.47e-03 | 8 | 138 | 2 | PF00052 | |
| Domain | LamB | 1.47e-03 | 8 | 138 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.47e-03 | 8 | 138 | 2 | IPR000034 | |
| Domain | - | 2.35e-03 | 10 | 138 | 2 | 1.10.220.60 | |
| Domain | TPR | 2.71e-03 | 129 | 138 | 5 | SM00028 | |
| Domain | TPR_repeat | 3.09e-03 | 133 | 138 | 5 | IPR019734 | |
| Domain | Kinesin-like_fam | 3.92e-03 | 43 | 138 | 3 | IPR027640 | |
| Domain | START_lipid-bd_dom | 5.34e-03 | 15 | 138 | 2 | IPR002913 | |
| Domain | START | 5.34e-03 | 15 | 138 | 2 | PF01852 | |
| Domain | START | 5.34e-03 | 15 | 138 | 2 | PS50848 | |
| Domain | WH2 | 6.08e-03 | 16 | 138 | 2 | PF02205 | |
| Domain | Ank | 7.01e-03 | 228 | 138 | 6 | PF00023 | |
| Pubmed | DLG5 ATAD5 NSD2 CEP290 SPAG9 GIT2 HUWE1 RFC1 ATAD2 SERF1A ESCO2 ODF2L EPS15L1 CBX5 ZNF638 ROCK1 RAI14 HMGN4 UTRN PCM1 HELLS | 3.32e-13 | 645 | 144 | 21 | 25281560 | |
| Pubmed | EPB41L4B KDM3B DNM1L TBC1D22B SPAG9 CEP192 HUWE1 ANKRD50 DMXL1 DHX9 RIF1 EPS15L1 VPS13A SLITRK5 ZNF638 TMF1 TJP2 PDS5A RAI14 PCM1 HELLS | 1.12e-11 | 777 | 144 | 21 | 35844135 | |
| Pubmed | TPR NSD2 COPB2 SPAG9 LMNB2 HUWE1 RFC1 ANKHD1 ATAD2 CRNKL1 RIF1 YLPM1 ZNF638 TJP2 PYGL PDS5A ATM UTRN PCM1 | 3.33e-11 | 653 | 144 | 19 | 22586326 | |
| Pubmed | TPR ATAD5 NSD2 COPB2 KDM3B NAP1L4 DNM1L MSH3 LMNB2 RFC1 DHX9 CRNKL1 RIF1 PPIG CBX5 YLPM1 PYGL PDS5A PHF14 ATM HMGN4 HELLS | 2.30e-10 | 1014 | 144 | 22 | 32416067 | |
| Pubmed | MON2 RGPD8 CEP290 NACA KDM3B UBAP1 LMNB2 HUWE1 JMJD1C NPTN YLPM1 ZNF638 MMGT1 TMF1 TJP2 ROCK1 CROCC VAMP4 PCM1 | 2.34e-10 | 733 | 144 | 19 | 34672954 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR ASXL1 RGPD8 NACA COPB2 RGPD1 NAP1L4 SPAG9 CEP192 HMMR DHX9 ORC1 CRNKL1 ODF2L EPS15L1 YLPM1 SYCP1 PDS5A RAI14 ATM KIFC3 PCM1 RGPD5 | 4.54e-10 | 1155 | 144 | 23 | 20360068 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD8 ATAD5 NSD2 COPB2 RGPD1 AAK1 DNM1L GIT2 KIF20B ORC1 RIF1 PPIG ZNF638 ATM | 5.26e-10 | 370 | 144 | 14 | 22922362 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR KIF27 NSD2 KIAA0586 NACA COPB2 DNM1L PSMD11 MSH3 LMNB2 HUWE1 RFC1 CMYA5 ANKHD1 TTC3 ATAD2 DHX9 CRNKL1 RIF1 STARD9 NEMF PDS5A ATM QARS1 HELLS | 9.88e-10 | 1425 | 144 | 25 | 30948266 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | AHI1 NSD2 CEP290 ZNF185 NAP1L4 DNM1L SPAG9 ANKHD1 TTC3 SERF1A LIG4 RIF1 ODF2L EPS15L1 RNF10 ZNF638 KIFC3 QARS1 PCM1 HELLS | 1.74e-09 | 925 | 144 | 20 | 28986522 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR NACA ZNF185 COPB2 AAK1 PSMD11 MSH3 LMNB2 HUWE1 RFC1 ANKHD1 ATAD2 KIF20B DHX9 ORC1 CRNKL1 RIF1 LLGL1 ZNF638 PYGL PDS5A RAI14 QARS1 UTRN | 1.80e-09 | 1353 | 144 | 24 | 29467282 |
| Pubmed | TET2 ASXL1 ATAD5 NACA COPB2 RGPD1 DACH1 NAP1L4 SPAG9 PSMD11 CEP192 RFC1 ANKHD1 JMJD1C MYO5C RIF1 ZFHX4 YLPM1 ZNF638 PDS5A RAI14 QARS1 PCM1 HELLS | 5.22e-09 | 1429 | 144 | 24 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ATAD5 NSD2 DACH1 RFC1 JMJD1C KIF20B DHX9 CRNKL1 RIF1 EPS15L1 CBX5 YLPM1 ZNF638 PDS5A PHF14 HMGN4 PCM1 HELLS | 1.71e-08 | 954 | 144 | 19 | 36373674 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR ASXL1 KIF27 COPB2 DACH1 SPAG9 MSH3 LMNB2 HUWE1 ANKHD1 JMJD1C LIG4 RIF1 ZFHX4 TMF1 PDS5A QARS1 HELLS | 1.88e-08 | 857 | 144 | 18 | 25609649 |
| Pubmed | TET2 TPR RGPD8 RGPD1 HUWE1 ANKHD1 JMJD1C KIF20B ZFHX4 TMF1 RAI14 UTRN PCM1 | 2.30e-08 | 418 | 144 | 13 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR AAK1 KDM3B SPAG9 HUWE1 RFC1 ATAD2 DHX9 RIF1 PPIG EPS15L1 YLPM1 ZNF638 TJP2 PHF14 ATM PCM1 | 2.53e-08 | 774 | 144 | 17 | 15302935 |
| Pubmed | TPR NACA AAK1 LAMC2 MSH3 LMNB2 ANKHD1 EPS15L1 SNCAIP ZNF638 TJP2 UTRN | 3.84e-08 | 360 | 144 | 12 | 33111431 | |
| Pubmed | TPR DLG5 COBLL1 COPB2 AAK1 DNM1L ANKRD50 JMJD1C DHX9 EPS15L1 LLGL1 SLITRK5 PDS5A ROCK1 RAI14 QARS1 | 4.53e-08 | 708 | 144 | 16 | 39231216 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ATAD5 NACA AAK1 KDM3B NAP1L4 DNM1L SPAG9 RFC1 ANKHD1 RIF1 EPS15L1 YLPM1 ZNF638 RAI14 UTRN PCM1 HELLS | 6.87e-08 | 934 | 144 | 18 | 33916271 |
| Pubmed | 7.36e-08 | 86 | 144 | 7 | 37253089 | ||
| Pubmed | MON2 ATAD5 NSD2 CEP290 COPB2 SPAG9 PSMD11 CEP192 HUWE1 RIF1 LNPEP YLPM1 VPS13A ZNF638 TMF1 ROCK1 RAI14 UTRN HELLS | 7.59e-08 | 1049 | 144 | 19 | 27880917 | |
| Pubmed | TPR DACH1 KDM3B NAP1L4 SPAG9 HUWE1 ANKHD1 JMJD1C EPS15L1 YLPM1 TJP2 RAI14 PCM1 RGPD5 | 7.64e-08 | 549 | 144 | 14 | 38280479 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ATAD5 NAP1L4 MSH3 RFC1 DHX9 RIF1 CBX5 ZNF638 PDS5A PHF14 QARS1 UTRN | 1.02e-07 | 394 | 144 | 12 | 27248496 |
| Pubmed | TPR COBLL1 WIPF3 KDM3B DNM1L LAMC2 KIF20B CRNKL1 RIF1 YLPM1 RAI14 QARS1 UTRN | 2.09e-07 | 506 | 144 | 13 | 30890647 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATAD5 NSD2 KDM3B MSH3 RFC1 ATAD2 JMJD1C KIF20B FSIP2 RIF1 CBX5 PDS5A PHF14 HELLS | 2.63e-07 | 608 | 144 | 14 | 36089195 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR CEP290 NACA PSMD11 LMNB2 HUWE1 MYO5C DHX9 CRNKL1 RIF1 CBX5 YLPM1 ZNF638 TJP2 QARS1 UTRN PCM1 HELLS | 2.67e-07 | 1024 | 144 | 18 | 24711643 |
| Pubmed | MON2 TPR RGPD8 NACA COPB2 RGPD1 AAK1 NAP1L4 PSMD11 HUWE1 KCNB2 EPS15L1 CACNG8 RABGAP1L RNF10 SLC4A10 SLITRK5 TJP2 PCM1 | 2.68e-07 | 1139 | 144 | 19 | 36417873 | |
| Pubmed | 3.08e-07 | 215 | 144 | 9 | 35973513 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPB41L4B TOPAZ1 CEP290 COPB2 SPAG9 LMNB2 HUWE1 OMG DHX9 ERRFI1 VPS13A PDS5A PHF14 ATM UTRN | 4.55e-07 | 736 | 144 | 15 | 29676528 |
| Pubmed | 5.65e-07 | 169 | 144 | 8 | 31462741 | ||
| Pubmed | EPB41L4B NACA KDM3B LAMC2 HMMR ANKRD50 ANKHD1 JMJD1C ACE2 LIG4 LLGL1 NEMF ZNF638 HELLS | 5.85e-07 | 650 | 144 | 14 | 38777146 | |
| Pubmed | TPR MAP9 AHI1 EPB41L4B COPB2 DNM1L CEP192 HUWE1 ANKRD50 ANKHD1 TTC3 ESCO2 ALKBH8 CBX5 ZNF638 TJP2 ROCK1 UTRN | 6.07e-07 | 1084 | 144 | 18 | 11544199 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 DLG5 COBLL1 AAK1 KDM3B DNM1L TBC1D22B CEP192 FSIP2 STARD9 RABGAP1L RNF10 TJP2 RAI14 UTRN PCM1 | 6.25e-07 | 861 | 144 | 16 | 36931259 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 SPAG1 EPB41L4B COBLL1 ZNF185 AAK1 TBC1D22B EPS15L1 LLGL1 SH3GLB1 TJP2 RAI14 UTRN | 7.25e-07 | 565 | 144 | 13 | 25468996 |
| Pubmed | TPR NAP1L4 DNM1L SPAG9 LMNB2 EPS15L1 VPS13A MMGT1 TMF1 RAI14 CROCC VAMP4 PCM1 | 7.69e-07 | 568 | 144 | 13 | 37774976 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 SPAG1 NACA ZNF185 COPB2 AAK1 KDM3B NAP1L4 PSMD11 HMMR HUWE1 RFC1 EPS15L1 YLPM1 TJP2 PYGL ROCK1 RAI14 QARS1 UTRN | 9.89e-07 | 1367 | 144 | 20 | 32687490 |
| Pubmed | 1.04e-06 | 19 | 144 | 4 | 24421332 | ||
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 1.06e-06 | 80 | 144 | 6 | 34591877 | |
| Pubmed | COBLL1 CEP290 KIAA0586 SPAG9 USP37 JMJD1C SH3GLB1 SLITRK5 PDS5A PHF14 TTC39A PLEKHH2 | 1.10e-06 | 493 | 144 | 12 | 15368895 | |
| Pubmed | SPAG1 CEP290 MSH3 HMMR CMYA5 ANKHD1 TTC3 ATAD2 CCDC7 FBXO16 STARD9 RABGAP1L SYCP1 ALPK2 | 1.10e-06 | 686 | 144 | 14 | 29987050 | |
| Pubmed | 1.44e-06 | 334 | 144 | 10 | 30425250 | ||
| Pubmed | TET2 CEP290 MSH3 HUWE1 CMYA5 TTC3 CRNKL1 ODF2L EPS15L1 NEMF YLPM1 RNF10 RAI14 ATM KIFC3 QARS1 UTRN MTUS2 PCM1 | 1.62e-06 | 1285 | 144 | 19 | 35914814 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.40e-06 | 7 | 144 | 3 | 15710750 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 SPAG1 AHI1 COBLL1 CEP290 AAK1 SPAG9 GIT2 HMMR DHX9 RIF1 EPS15L1 SH3GLB1 RABGAP1L ZNF638 PYGL RAI14 QARS1 BBS12 | 2.43e-06 | 1321 | 144 | 19 | 27173435 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 NACA COPB2 KDM3B NAP1L4 UBAP1 DNM1L SPAG9 PSMD11 HUWE1 CMYA5 DHX9 EPS15L1 SH3GLB1 LNPEP TJP2 PYGL ROCK1 CROCC QARS1 | 2.56e-06 | 1455 | 144 | 20 | 22863883 |
| Pubmed | COPB2 NAP1L4 DNM1L SPAG9 PSMD11 LMNB2 HUWE1 DHX9 CRNKL1 RIF1 PDS5A QARS1 HELLS | 2.77e-06 | 638 | 144 | 13 | 33239621 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPB41L4B NSD2 BLNK AAK1 LAMA3 CEP192 HUWE1 TTC3 JMJD1C FBXO16 ARHGAP6 ODF2L EPS15L1 NEMF ZNF638 PHF14 RAI14 CROCC UTRN PCM1 | 3.61e-06 | 1489 | 144 | 20 | 28611215 |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 3.66e-06 | 56 | 144 | 5 | 9455484 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.69e-06 | 153 | 144 | 7 | 26365490 | |
| Pubmed | DLG5 ATAD5 NSD2 NACA AAK1 NAP1L4 HMMR ANKHD1 ATAD2 KIF20B ORC1 CRNKL1 RIF1 LNPEP TMF1 PDS5A PHF14 RAI14 CROCC UTRN | 3.91e-06 | 1497 | 144 | 20 | 31527615 | |
| Pubmed | CEP290 NAP1L4 HUWE1 RFC1 CRNKL1 CBX5 ZNF638 PDS5A PHF14 UNC79 HELLS | 4.47e-06 | 469 | 144 | 11 | 27634302 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 5.34e-06 | 28 | 144 | 4 | 20309963 | |
| Pubmed | 5.73e-06 | 9 | 144 | 3 | 27146717 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR NACA COPB2 NAP1L4 DNM1L SPAG9 PSMD11 HUWE1 RFC1 ANKHD1 DHX9 SH3GLB1 NEMF PYGL PDS5A RAI14 QARS1 | 5.94e-06 | 1149 | 144 | 17 | 35446349 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR KIF27 COPB2 DNM1L PSMD11 HUWE1 DHX9 RIF1 YLPM1 ZNF638 ATM HELLS | 6.03e-06 | 582 | 144 | 12 | 20467437 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 7.19e-06 | 111 | 144 | 6 | 22558309 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATAD5 NSD2 CEP290 MSH3 LMNB2 RFC1 JMJD1C DHX9 ORC1 RIF1 PPIG CBX5 YLPM1 ZNF638 PDS5A PHF14 HMGN4 HELLS | 7.22e-06 | 1294 | 144 | 18 | 30804502 |
| Pubmed | TPR NACA COPB2 SPAG9 PSMD11 HMMR KIF20B DHX9 PYGL PDS5A QARS1 | 7.29e-06 | 494 | 144 | 11 | 26831064 | |
| Pubmed | TPR COBLL1 AAK1 HUWE1 RFC1 RIF1 EPS15L1 ZNF638 TMF1 TJP2 PCM1 | 8.63e-06 | 503 | 144 | 11 | 16964243 | |
| Pubmed | 1.09e-05 | 332 | 144 | 9 | 25693804 | ||
| Pubmed | TPR RGPD8 RGPD1 AAK1 DNM1L LMNB2 GIT2 HUWE1 TTC3 NPTN EPS15L1 YLPM1 ROCK1 UNC79 PCM1 | 1.19e-05 | 963 | 144 | 15 | 28671696 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.23e-05 | 256 | 144 | 8 | 33397691 | |
| Pubmed | NAP1L4 DNM1L TBC1D22B EPS15L1 LNPEP RABGAP1L TMF1 RAI14 CROCC | 1.28e-05 | 339 | 144 | 9 | 37232246 | |
| Pubmed | 1.42e-05 | 125 | 144 | 6 | 29467281 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ATAD5 NSD2 DACH1 MSH3 RFC1 ATAD2 RIF1 CBX5 CROCC HMGN4 HELLS | 1.48e-05 | 533 | 144 | 11 | 30554943 |
| Pubmed | 1.49e-05 | 263 | 144 | 8 | 34702444 | ||
| Pubmed | DLG5 COBLL1 NACA AAK1 HMMR RFC1 ANKHD1 ESCO2 CRNKL1 RIF1 PPIG STARD9 NEMF YLPM1 TJP2 RAI14 QARS1 PCM1 | 1.57e-05 | 1371 | 144 | 18 | 36244648 | |
| Pubmed | Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. | 1.70e-05 | 2 | 144 | 2 | 24218140 | |
| Pubmed | Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia. | 1.70e-05 | 2 | 144 | 2 | 26771811 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23028714 | ||
| Pubmed | Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. | 1.70e-05 | 2 | 144 | 2 | 20334914 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18502721 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 37288803 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11810295 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 15454574 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26386044 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30454965 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9010770 | ||
| Pubmed | Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. | 1.70e-05 | 2 | 144 | 2 | 32277367 | |
| Pubmed | Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. | 1.70e-05 | 2 | 144 | 2 | 23009937 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 25596262 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12406326 | ||
| Pubmed | Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. | 1.70e-05 | 2 | 144 | 2 | 26095772 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31578315 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24465546 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 20683928 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 35306971 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF185 AAK1 DACH1 KDM3B SPAG9 HMMR JMJD1C EPS15L1 PDS5A HELLS | 1.74e-05 | 444 | 144 | 10 | 34795231 |
| Pubmed | TPR NACA PSMD11 HUWE1 ANKHD1 EPS15L1 LNPEP STARD9 MMGT1 UTRN | 1.92e-05 | 449 | 144 | 10 | 31732153 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.33e-05 | 203 | 144 | 7 | 22083510 | |
| Pubmed | Tet1 controls meiosis by regulating meiotic gene expression. | 2.45e-05 | 14 | 144 | 3 | 23151479 | |
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 22346761 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.52e-05 | 283 | 144 | 8 | 30585729 | |
| Pubmed | 2.80e-05 | 209 | 144 | 7 | 36779422 | ||
| Pubmed | Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. | 2.85e-05 | 85 | 144 | 5 | 19596235 | |
| Pubmed | TPR NACA COPB2 PSMD11 LMNB2 GIT2 HUWE1 ARHGAP6 RIF1 EPS15L1 TJP2 PDS5A HMGN4 UTRN | 2.91e-05 | 916 | 144 | 14 | 32203420 | |
| Pubmed | CEP290 WIPF3 DNM1L PSMD11 OMG KIF20B NPTN EPS15L1 RNF10 PYGL ROCK1 PLEKHH2 | 3.19e-05 | 689 | 144 | 12 | 36543142 | |
| Pubmed | 3.36e-05 | 44 | 144 | 4 | 30886144 | ||
| Pubmed | 3.42e-05 | 146 | 144 | 6 | 21399614 | ||
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 3.96e-05 | 91 | 144 | 5 | 34780483 | |
| Pubmed | 4.18e-05 | 304 | 144 | 8 | 32235678 | ||
| Interaction | PFN1 interactions | MON2 TPR MAP9 DLG5 COBLL1 WIPF3 AAK1 DNM1L CEP192 GIT2 ANKHD1 MYO5C ACE2 LIG4 PPIG RABGAP1L TMF1 TJP2 QARS1 | 3.27e-09 | 509 | 142 | 19 | int:PFN1 |
| Interaction | NDC80 interactions | MAP9 DLG5 CEP290 CEP192 HMMR MYO5C ESCO2 ODF2L EPS15L1 SH3GLB1 ROCK1 KIFC3 PCM1 | 3.33e-07 | 312 | 142 | 13 | int:NDC80 |
| Interaction | MED4 interactions | DLG5 AHI1 CEP290 SPAG9 GIT2 HUWE1 SERF1A ODF2L EPS15L1 ZNF638 RAI14 KIFC3 UTRN PCM1 RGPD5 | 6.96e-07 | 450 | 142 | 15 | int:MED4 |
| Interaction | APEX1 interactions | AHI1 ATAD5 NSD2 CEP290 ZNF185 DACH1 NAP1L4 DNM1L SPAG9 RFC1 ANKHD1 TTC3 SERF1A KIF20B LIG4 RIF1 ODF2L EPS15L1 RNF10 ZNF638 PDS5A ATM KIFC3 QARS1 PCM1 HELLS | 7.96e-07 | 1271 | 142 | 26 | int:APEX1 |
| Interaction | KCNA3 interactions | TPR DLG5 COBLL1 NACA COPB2 AAK1 DNM1L ANKRD50 JMJD1C MYO5C DHX9 ORC1 EPS15L1 LLGL1 VPS13A SLITRK5 PYGL PDS5A ROCK1 RAI14 QARS1 | 8.09e-07 | 871 | 142 | 21 | int:KCNA3 |
| Interaction | ANKRD50 interactions | 9.69e-07 | 108 | 142 | 8 | int:ANKRD50 | |
| Interaction | PHF21A interactions | TPR GIT2 HUWE1 ANKHD1 JMJD1C KIF20B ESCO2 ZFHX4 RABGAP1L TMF1 RAI14 UTRN PCM1 | 9.70e-07 | 343 | 142 | 13 | int:PHF21A |
| Interaction | SIRT7 interactions | TPR NSD2 COPB2 SPAG9 LMNB2 HUWE1 RFC1 ANKHD1 ATAD2 CRNKL1 RIF1 YLPM1 ZNF638 TJP2 PYGL PDS5A ATM UTRN PCM1 | 1.23e-06 | 744 | 142 | 19 | int:SIRT7 |
| Interaction | H3C1 interactions | TPR ATAD5 NSD2 COBLL1 CEP290 NACA SPAG9 MSH3 RFC1 ATAD2 JMJD1C KIF20B ESCO2 ACE2 RIF1 CBX5 ZNF638 PDS5A ATM HMGN4 HELLS | 1.39e-06 | 901 | 142 | 21 | int:H3C1 |
| Interaction | MCM4 interactions | NACA COPB2 SPAG9 HUWE1 USP37 ESCO2 ORC1 LIG4 EPS15L1 NEMF TJP2 HELLS | 1.82e-06 | 306 | 142 | 12 | int:MCM4 |
| Interaction | EED interactions | TPR ASXL1 NSD2 CEP290 COPB2 DNM1L PSMD11 MSH3 LMNB2 HUWE1 ATAD2 KIF20B DMXL1 DHX9 ORC1 CRNKL1 RIF1 EPS15L1 YLPM1 RNF10 ZNF638 TJP2 PDS5A RAI14 CROCC PCM1 HELLS | 2.68e-06 | 1445 | 142 | 27 | int:EED |
| Interaction | GOLGA1 interactions | 6.11e-06 | 183 | 142 | 9 | int:GOLGA1 | |
| Interaction | ANAPC2 interactions | DLG5 RGPD8 KIAA0586 CEP192 ANKHD1 TTC3 MYO5C NPTN ODF2L STAG3 | 6.41e-06 | 234 | 142 | 10 | int:ANAPC2 |
| Interaction | HDAC1 interactions | TET2 TPR NSD2 DACH1 SPAG9 PSMD11 RFC1 USP37 ANKHD1 JMJD1C KIF20B ESCO2 ZFHX4 ZNF638 TMF1 PHF14 RAI14 ATM CROCC UTRN PCM1 HELLS | 1.01e-05 | 1108 | 142 | 22 | int:HDAC1 |
| Interaction | SUB1 interactions | 1.03e-05 | 247 | 142 | 10 | int:SUB1 | |
| Interaction | RCOR1 interactions | TPR SPAG9 GIT2 HUWE1 ANKHD1 JMJD1C KIF20B ESCO2 ZFHX4 RABGAP1L TMF1 RAI14 UTRN PCM1 | 1.08e-05 | 494 | 142 | 14 | int:RCOR1 |
| Interaction | H3C3 interactions | ATAD5 NSD2 KDM3B MSH3 RFC1 ATAD2 JMJD1C KIF20B FSIP2 RIF1 CBX5 PDS5A PHF14 HELLS | 1.10e-05 | 495 | 142 | 14 | int:H3C3 |
| Interaction | FBXO42 interactions | 1.55e-05 | 259 | 142 | 10 | int:FBXO42 | |
| Interaction | PPIA interactions | CACNA1D ASXL1 DLG5 EPB41L4B NSD2 NACA DNM1L TBC1D22B HMMR HUWE1 RFC1 ANKRD50 ESCO2 ACE2 LIG4 RIF1 LLGL1 STARD9 ERRFI1 | 1.56e-05 | 888 | 142 | 19 | int:PPIA |
| Interaction | STX6 interactions | MON2 DLG5 COPB2 TBC1D22B DMXL1 EPS15L1 LLGL1 LNPEP MMGT1 TMF1 RAI14 VAMP4 UTRN | 1.76e-05 | 448 | 142 | 13 | int:STX6 |
| Interaction | ZFPL1 interactions | MON2 DLG5 COPB2 DNM1L TBC1D22B SPAG9 KCNB2 LLGL1 LNPEP TMF1 RAI14 VAMP4 UTRN | 1.76e-05 | 448 | 142 | 13 | int:ZFPL1 |
| Interaction | RAB11A interactions | MON2 TPR NAP1L4 DNM1L TBC1D22B KCNB2 DMXL1 MYO5C ACE2 EPS15L1 LLGL1 LNPEP RABGAP1L VPS13A SLITRK5 TMF1 RAI14 VAMP4 | 2.23e-05 | 830 | 142 | 18 | int:RAB11A |
| Interaction | GAPDH interactions | TET2 ASXL1 CEP290 KDM3B PSMD11 HUWE1 RFC1 SERF1A DHX9 ACE2 LIG4 RIF1 SH3GLB1 MMGT1 CROCC QARS1 | 2.76e-05 | 686 | 142 | 16 | int:GAPDH |
| Interaction | YWHAH interactions | TET2 DLG5 COBLL1 CEP290 AAK1 KDM3B DNM1L TBC1D22B CEP192 GIT2 HUWE1 SNCAIP STARD9 RABGAP1L ERRFI1 RNF10 ZNF638 TJP2 RAI14 UTRN PCM1 | 3.02e-05 | 1102 | 142 | 21 | int:YWHAH |
| Interaction | ACTC1 interactions | TPR FBXO40 COBLL1 WIPF3 KDM3B DNM1L LAMC2 KIF20B MYO5C CRNKL1 RIF1 YLPM1 ERRFI1 RAI14 QARS1 UTRN | 3.17e-05 | 694 | 142 | 16 | int:ACTC1 |
| Interaction | SYCE1 interactions | 3.28e-05 | 127 | 142 | 7 | int:SYCE1 | |
| Interaction | KDM1A interactions | TET2 TPR DLG5 NSD2 HUWE1 ANKHD1 JMJD1C KIF20B ESCO2 ACE2 ZFHX4 RABGAP1L RNF10 TMF1 PDS5A RAI14 KIFC3 UTRN PCM1 | 3.45e-05 | 941 | 142 | 19 | int:KDM1A |
| Interaction | ENO1 interactions | TET2 ASXL1 NSD2 NAP1L4 UBAP1 CEP192 HUWE1 ANKHD1 ACE2 LIG4 CBX5 VPS13A SYCP1 RNF10 ZNF638 MMGT1 | 3.58e-05 | 701 | 142 | 16 | int:ENO1 |
| Interaction | SVIL interactions | 4.17e-05 | 233 | 142 | 9 | int:SVIL | |
| Interaction | JPH3 interactions | 4.24e-05 | 55 | 142 | 5 | int:JPH3 | |
| Interaction | USP14 interactions | NACA COPB2 PSMD11 LMNB2 DHX9 RIF1 SH3GLB1 CBX5 PHF14 RAI14 QARS1 HMGN4 RGPD5 | 4.36e-05 | 489 | 142 | 13 | int:USP14 |
| Interaction | FOXB1 interactions | 4.86e-05 | 135 | 142 | 7 | int:FOXB1 | |
| Interaction | PCNA interactions | ASXL1 NACA2 SPAG1 ATAD5 NSD2 MSH3 HUWE1 RFC1 USP37 DHX9 ESCO2 ERRFI1 ATM | 5.15e-05 | 497 | 142 | 13 | int:PCNA |
| Interaction | FOXP3 interactions | ATAD5 NSD2 COPB2 AAK1 DNM1L GIT2 KIF20B ORC1 RIF1 PPIG ZNF638 ATM | 5.71e-05 | 432 | 142 | 12 | int:FOXP3 |
| Interaction | HMG20A interactions | 5.96e-05 | 244 | 142 | 9 | int:HMG20A | |
| Interaction | ZNF280C interactions | 7.01e-05 | 61 | 142 | 5 | int:ZNF280C | |
| Interaction | SMC5 interactions | TPR ATAD5 NSD2 DACH1 RFC1 JMJD1C KIF20B DHX9 CRNKL1 RIF1 EPS15L1 CBX5 YLPM1 ZNF638 PDS5A PHF14 HMGN4 PCM1 HELLS | 7.80e-05 | 1000 | 142 | 19 | int:SMC5 |
| Interaction | XRCC6 interactions | TPR ASXL1 NSD2 DACH1 DNM1L HUWE1 RFC1 JMJD1C DHX9 ORC1 ACE2 LIG4 RIF1 CBX5 YLPM1 ZNF638 HMGN4 HELLS | 9.42e-05 | 928 | 142 | 18 | int:XRCC6 |
| Interaction | AFDN interactions | 1.28e-04 | 333 | 142 | 10 | int:AFDN | |
| Interaction | VPS35 interactions | 1.29e-04 | 270 | 142 | 9 | int:VPS35 | |
| Interaction | CDC42 interactions | DLG5 EPB41L4B COBLL1 WIPF3 PSMD11 MSH3 LMNB2 GIT2 HUWE1 DHX9 LLGL1 LNPEP ERRFI1 VPS13A SLITRK5 MMGT1 ROCK1 RAI14 KIFC3 UTRN PCM1 MAP3K19 | 1.44e-04 | 1323 | 142 | 22 | int:CDC42 |
| Interaction | H2BC3 interactions | ATAD5 NAP1L4 RFC1 DHX9 ACE2 RIF1 PDS5A PHF14 QARS1 HMGN4 UTRN | 1.46e-04 | 406 | 142 | 11 | int:H2BC3 |
| Interaction | TERF2IP interactions | ATAD5 NSD2 DACH1 KDM3B MSH3 RFC1 KIF20B ORC1 RIF1 ZNF638 PDS5A HMGN4 HELLS | 1.47e-04 | 552 | 142 | 13 | int:TERF2IP |
| Interaction | SOX2 interactions | TET2 DLG5 ATAD5 ZNF185 DACH1 NAP1L4 LAMA3 DNM1L PSMD11 LMNB2 RFC1 ANKHD1 TTC3 JMJD1C DHX9 ZFHX4 CBX5 YLPM1 ZNF638 TEKT1 RAI14 QARS1 SPINK5 | 1.51e-04 | 1422 | 142 | 23 | int:SOX2 |
| Interaction | IFI16 interactions | TPR RGPD8 NSD2 HUWE1 RFC1 ATAD2 DHX9 CRNKL1 CBX5 RABGAP1L NEMF ZNF638 PHF14 RAI14 QARS1 | 1.59e-04 | 714 | 142 | 15 | int:IFI16 |
| Interaction | MCM7 interactions | ASXL1 CEP290 COPB2 SPAG9 HUWE1 ESCO2 ORC1 ACE2 TJP2 KIFC3 HELLS | 1.73e-04 | 414 | 142 | 11 | int:MCM7 |
| Interaction | CPNE3 interactions | 1.73e-04 | 116 | 142 | 6 | int:CPNE3 | |
| Interaction | LYN interactions | DLG5 EPB41L4B NSD2 COBLL1 BLNK NAP1L4 ANKRD50 KCNB2 LLGL1 LNPEP VPS13A ROCK1 RAI14 PLEKHH2 UTRN | 1.74e-04 | 720 | 142 | 15 | int:LYN |
| Interaction | IGSF21 interactions | 1.77e-04 | 40 | 142 | 4 | int:IGSF21 | |
| Interaction | HMGN2 interactions | 1.81e-04 | 222 | 142 | 8 | int:HMGN2 | |
| Interaction | NAA40 interactions | TPR ATAD5 NACA AAK1 KDM3B NAP1L4 DNM1L SPAG9 RFC1 ANKHD1 RIF1 EPS15L1 YLPM1 ZNF638 RAI14 UTRN PCM1 HELLS | 1.81e-04 | 978 | 142 | 18 | int:NAA40 |
| Interaction | ATG16L1 interactions | MON2 DLG5 COBLL1 KIAA0586 ZNF185 NAP1L4 UBAP1 CEP192 GIT2 ANKRD50 DHX9 EPS15L1 LNPEP CBX5 YLPM1 ZNF638 TMF1 ATM PCM1 RGPD5 | 1.88e-04 | 1161 | 142 | 20 | int:ATG16L1 |
| Interaction | SMC1A interactions | SPAG9 HUWE1 RFC1 USP37 ACE2 RIF1 EPS15L1 NEMF PDS5A ATM STAG3 | 1.88e-04 | 418 | 142 | 11 | int:SMC1A |
| Interaction | IMPDH2 interactions | ASXL1 DLG5 AAK1 DNM1L PSMD11 HUWE1 MYO5C ACE2 MMGT1 TJP2 ROCK1 | 1.96e-04 | 420 | 142 | 11 | int:IMPDH2 |
| Interaction | INSYN1 interactions | 1.98e-04 | 169 | 142 | 7 | int:INSYN1 | |
| Interaction | MCM6 interactions | 2.04e-04 | 287 | 142 | 9 | int:MCM6 | |
| Interaction | RAB35 interactions | DLG5 SPAG1 EPB41L4B DMXL1 ACE2 LLGL1 LNPEP RABGAP1L VPS13A ROCK1 RAI14 VAMP4 UTRN | 2.12e-04 | 573 | 142 | 13 | int:RAB35 |
| Interaction | MCM2 interactions | TPR RGPD8 NACA COPB2 RGPD1 SPAG9 HUWE1 CMYA5 DHX9 ESCO2 ORC1 EPS15L1 SYCP1 TJP2 PYGL ATM QARS1 UTRN RGPD5 | 2.14e-04 | 1081 | 142 | 19 | int:MCM2 |
| Interaction | BICD2 interactions | TPR RGPD8 ZNF185 RGPD1 AAK1 NAP1L4 UBAP1 CEP192 TJP2 PCM1 RGPD5 | 2.21e-04 | 426 | 142 | 11 | int:BICD2 |
| Interaction | H2BC8 interactions | ATAD5 NSD2 DACH1 MSH3 RFC1 ATAD2 KIF20B ESCO2 RIF1 CBX5 PDS5A PHF14 HELLS | 2.23e-04 | 576 | 142 | 13 | int:H2BC8 |
| Interaction | GYPA interactions | 2.37e-04 | 174 | 142 | 7 | int:GYPA | |
| Interaction | NPIPB6 interactions | 2.59e-04 | 18 | 142 | 3 | int:NPIPB6 | |
| Interaction | PSENEN interactions | 2.70e-04 | 81 | 142 | 5 | int:PSENEN | |
| Interaction | RHOF interactions | DLG5 MSH3 LMNB2 GIT2 ANKRD50 ATAD2 LLGL1 LNPEP VPS13A SLITRK5 ROCK1 RAI14 UTRN HELLS | 2.93e-04 | 673 | 142 | 14 | int:RHOF |
| Interaction | XRCC5 interactions | TPR DNM1L LMNB2 HUWE1 RFC1 DHX9 ORC1 ACE2 LIG4 ROCK1 ATM HMGN4 | 2.94e-04 | 515 | 142 | 12 | int:XRCC5 |
| Interaction | RHOQ interactions | DLG5 GIT2 KCNB2 DMXL1 LLGL1 LNPEP VPS13A SLITRK5 ROCK1 RAI14 UTRN | 3.03e-04 | 442 | 142 | 11 | int:RHOQ |
| Interaction | H2AZ1 interactions | 3.06e-04 | 371 | 142 | 10 | int:H2AZ1 | |
| Interaction | TEAD2 interactions | 3.21e-04 | 130 | 142 | 6 | int:TEAD2 | |
| Interaction | YWHAQ interactions | TET2 TPR DLG5 COBLL1 AAK1 DNM1L SPAG9 PSMD11 CEP192 RFC1 DHX9 ACE2 STARD9 ERRFI1 ZNF638 TJP2 RAI14 UNC79 PCM1 | 3.26e-04 | 1118 | 142 | 19 | int:YWHAQ |
| Interaction | CSK interactions | SPAG1 CEP290 MSH3 HMMR CMYA5 ANKHD1 TTC3 ATAD2 CCDC7 FBXO16 ACE2 STARD9 RABGAP1L SYCP1 TJP2 ALPK2 | 3.80e-04 | 861 | 142 | 16 | int:CSK |
| Interaction | CEP43 interactions | 4.04e-04 | 190 | 142 | 7 | int:CEP43 | |
| Interaction | KIF20A interactions | RGPD8 COPB2 NAP1L4 SPAG9 LMNB2 DHX9 ESCO2 ACE2 CBX5 RABGAP1L YLPM1 ZNF638 TJP2 RAI14 KIFC3 UTRN STAG3 PCM1 | 4.37e-04 | 1052 | 142 | 18 | int:KIF20A |
| Interaction | RAB5A interactions | MON2 TPR DNM1L TBC1D22B DMXL1 DHX9 LLGL1 SH3GLB1 LNPEP TMF1 ROCK1 RAI14 VAMP4 QARS1 | 4.74e-04 | 706 | 142 | 14 | int:RAB5A |
| Interaction | RGPD4 interactions | 4.78e-04 | 22 | 142 | 3 | int:RGPD4 | |
| Interaction | YWHAG interactions | TET2 DLG5 COBLL1 AAK1 KDM3B DNM1L TBC1D22B CEP192 GIT2 HUWE1 USP37 PPIG STARD9 RABGAP1L ERRFI1 ZNF638 TJP2 RAI14 UTRN PCM1 | 4.79e-04 | 1248 | 142 | 20 | int:YWHAG |
| Interaction | NXF1 interactions | TPR RGPD1 DACH1 NAP1L4 UBAP1 CEP192 MSH3 ANKHD1 ATAD2 DHX9 CCDC7 ESCO2 ODF2L EPS15L1 RABGAP1L YLPM1 RNF10 ROCK1 QARS1 MTUS2 RGPD5 | 4.82e-04 | 1345 | 142 | 21 | int:NXF1 |
| Interaction | BFSP1 interactions | 4.92e-04 | 52 | 142 | 4 | int:BFSP1 | |
| Interaction | UQCR11 interactions | 5.29e-04 | 53 | 142 | 4 | int:UQCR11 | |
| Interaction | CCDC92 interactions | 5.29e-04 | 53 | 142 | 4 | int:CCDC92 | |
| Interaction | UHRF2 interactions | 5.49e-04 | 200 | 142 | 7 | int:UHRF2 | |
| Interaction | PIBF1 interactions | 5.49e-04 | 200 | 142 | 7 | int:PIBF1 | |
| Interaction | HOOK3 interactions | 5.82e-04 | 202 | 142 | 7 | int:HOOK3 | |
| Interaction | RAB25 interactions | 5.92e-04 | 265 | 142 | 8 | int:RAB25 | |
| Interaction | PHLPP1 interactions | 6.02e-04 | 333 | 142 | 9 | int:PHLPP1 | |
| Interaction | TPX2 interactions | 6.17e-04 | 204 | 142 | 7 | int:TPX2 | |
| Interaction | TCP10L3 interactions | 6.22e-04 | 24 | 142 | 3 | int:TCP10L3 | |
| Interaction | AR interactions | TET2 TPR ASXL1 NSD2 BLNK KDM3B PSMD11 HUWE1 JMJD1C MYO5C DHX9 CRNKL1 CBX5 YLPM1 TMF1 PDS5A PCM1 | 6.25e-04 | 992 | 142 | 17 | int:AR |
| Interaction | OBSL1 interactions | TPR PSMD11 LMNB2 HUWE1 RFC1 DHX9 CRNKL1 RIF1 CBX5 NEMF YLPM1 ZNF638 TJP2 UTRN ALPK2 PCM1 | 6.30e-04 | 902 | 142 | 16 | int:OBSL1 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.58e-05 | 115 | 97 | 6 | 769 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.07e-04 | 46 | 97 | 4 | 622 | |
| GeneFamily | AAA ATPases | 1.86e-04 | 53 | 97 | 4 | 413 | |
| GeneFamily | Laminin subunits | 1.82e-03 | 12 | 97 | 2 | 626 | |
| GeneFamily | Ankyrin repeat domain containing | 1.94e-03 | 242 | 97 | 6 | 403 | |
| GeneFamily | StAR related lipid transfer domain containing | 2.86e-03 | 15 | 97 | 2 | 759 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | AHI1 CEP290 DNM1L CEP192 MSH3 HMMR RFC1 ANKHD1 ATAD2 KIF20B DMXL1 LIG4 RIF1 PPIG RABGAP1L NEMF ZNF638 TMF1 RAI14 ATM PCM1 HELLS | 8.89e-12 | 656 | 142 | 22 | M18979 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | TET2 ASXL1 SLC9A9 NSD2 PSMD11 USP37 ATAD2 RIF1 ATM UTRN PCM1 | 4.31e-09 | 180 | 142 | 11 | M8239 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MAP9 AHI1 ATAD5 NSD2 MSH3 HMMR RFC1 USP37 KCNB2 TTC3 ATAD2 KIF20B DHX9 RIF1 ODF2L CBX5 UNC79 PCM1 HELLS | 5.33e-09 | 680 | 142 | 19 | MM456 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | TPR KIAA0586 DNM1L MANEA LMNB2 RFC1 ATAD2 KIF20B DHX9 RIF1 ODF2L LNPEP CBX5 NEMF PHF14 RAI14 HELLS | 8.19e-08 | 644 | 142 | 17 | M10501 |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 8.56e-07 | 242 | 142 | 10 | M2128 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 1.53e-06 | 200 | 142 | 9 | M9354 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | TPR MUC15 CEP290 SPAG9 USP37 TTC3 DHX9 ESCO2 RIF1 PPIG SNCAIP HELLS | 2.19e-06 | 404 | 142 | 12 | M19488 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | ATAD5 NSD2 KIAA0586 CEP192 MSH3 LMNB2 HMMR USP37 NREP ATAD2 KIF20B ESCO2 ORC1 RIF1 CBX5 MMGT1 STAG3 HELLS | 3.44e-06 | 939 | 142 | 18 | M45768 |
| Coexpression | FISCHER_DREAM_TARGETS | ASXL1 AHI1 ATAD5 NSD2 SPAG9 CEP192 MSH3 HMMR RFC1 USP37 ATAD2 KIF20B ESCO2 ORC1 RIF1 ZNF45 CBX5 HELLS | 5.31e-06 | 969 | 142 | 18 | M149 |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP | 1.40e-05 | 200 | 142 | 8 | M4574 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_DN | 1.40e-05 | 200 | 142 | 8 | M4750 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ATAD5 NSD2 KIAA0586 CEP192 LMNB2 HMMR ATAD2 KIF20B ESCO2 ORC1 RIF1 ROCK1 HELLS | 1.66e-05 | 578 | 142 | 13 | M2368 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.13e-05 | 212 | 142 | 8 | M39221 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ATAD5 NSD2 KIAA0586 CEP192 LMNB2 HMMR ATAD2 KIF20B ESCO2 ORC1 RIF1 ROCK1 HELLS | 2.32e-05 | 597 | 142 | 13 | MM1309 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | AHI1 ATAD5 NSD2 CEP192 LMNB2 HMMR USP37 ATAD2 KIF20B ESCO2 ORC1 RIF1 CBX5 HELLS | 2.59e-05 | 694 | 142 | 14 | M45767 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | DLG5 ATAD5 NSD2 COBLL1 TBC1D22B SPAG9 LMNB2 HMMR NREP ATAD2 KIF20B CCDC7 ESCO2 ORC1 ZNF45 TJP2 | 2.81e-05 | 892 | 142 | 16 | M18120 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 3.04e-05 | 290 | 142 | 9 | M45736 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP | 4.14e-05 | 116 | 142 | 6 | M14146 | |
| Coexpression | IVANOV_MUTATED_IN_COLON_CANCER | 4.28e-05 | 13 | 142 | 3 | M5989 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR AAK1 NAP1L4 GIT2 HUWE1 JMJD1C DHX9 RIF1 PPIG GVINP1 LNPEP RABGAP1L NEMF ZNF638 TMF1 PDS5A ROCK1 ATM HMGN4 UTRN PCM1 | 5.50e-05 | 1492 | 142 | 21 | M40023 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 5.84e-05 | 180 | 142 | 7 | M8127 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | ATAD5 NSD2 LMNB2 HMMR ATAD2 KIF20B ESCO2 ORC1 RIF1 CBX5 HELLS | 6.18e-05 | 478 | 142 | 11 | M45785 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 6.49e-05 | 183 | 142 | 7 | M2993 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 KDM3B SPAG9 MSH3 HMMR NREP KIF20B RIF1 RABGAP1L VPS13A ZNF638 TJP2 PDS5A ROCK1 PHF14 | 6.59e-05 | 856 | 142 | 15 | M4500 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NSD2 NACA NAP1L4 LAMC2 LMNB2 HMMR KIF20B DHX9 RIF1 PPIG PDS5A TTC39A ATM HMGN4 | 6.99e-05 | 761 | 142 | 14 | M11961 |
| Coexpression | DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS | MAP9 SPAG1 KIF27 CEP290 CCDC160 OMG ODF2L TEKT1 CROCC BBS12 PPP1R42 PCM1 MAP3K19 | 8.49e-05 | 678 | 142 | 13 | M40124 |
| Coexpression | GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP | 9.66e-05 | 195 | 142 | 7 | M3098 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | 1.06e-04 | 198 | 142 | 7 | M325 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN | 1.13e-04 | 200 | 142 | 7 | M7709 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 1.13e-04 | 200 | 142 | 7 | M7177 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.13e-04 | 200 | 142 | 7 | M7168 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP | 1.13e-04 | 200 | 142 | 7 | M5613 | |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 1.13e-04 | 139 | 142 | 6 | M6451 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 1.45e-04 | 49 | 142 | 4 | M10412 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | TPR DNM1L HMMR RFC1 ANKHD1 TTC3 ATAD2 KIF20B DHX9 LIG4 RIF1 LNPEP NEMF | 1.56e-04 | 721 | 142 | 13 | M10237 |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 1.84e-04 | 152 | 142 | 6 | M2964 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SPAG9 HUWE1 ANKHD1 ATAD2 KIF20B FBXO16 ORC1 RIF1 ODF2L CBX5 NEMF ERRFI1 HELLS | 1.86e-04 | 734 | 142 | 13 | M3835 |
| Coexpression | BENPORATH_CYCLING_GENES | ASXL1 AHI1 KIAA0586 PSMD11 HMMR ATAD2 JMJD1C KIF20B ORC1 ROCK1 STAG3 HELLS | 2.21e-04 | 648 | 142 | 12 | M8156 |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 2.60e-04 | 162 | 142 | 6 | M6847 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 3.16e-04 | 168 | 142 | 6 | M18811 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ZNF410 RGPD8 SPAG9 RFC1 ATAD2 JMJD1C FBXO16 RIF1 RNF10 TMF1 PDS5A RGPD5 | 3.41e-04 | 680 | 142 | 12 | M41089 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 3.47e-04 | 171 | 142 | 6 | M39234 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | AHI1 ATAD5 CEP290 KIAA0586 ANKHD1 KIF20B RIF1 PPIG ODF2L NEMF PDS5A ROCK1 PHF14 PCM1 MAP3K19 | 2.55e-09 | 311 | 141 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | TPR AHI1 CEP290 CEP192 USP37 KIF20B YLPM1 ZNF638 TMF1 ROCK1 PHF14 PCM1 | 4.26e-09 | 186 | 141 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ATAD5 CEP290 DACH1 CEP192 USP37 TTC3 ATAD2 KIF20B DHX9 RIF1 NEMF ZNF638 TMF1 PDS5A ROCK1 ATM BBS12 | 9.44e-08 | 532 | 141 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR AHI1 ATAD5 NSD2 CEP290 KIAA0586 CEP192 EFCAB14 HMMR RFC1 ATAD2 KIF20B ESCO2 ORC1 LIG4 RIF1 PPIG ODF2L NEMF VPS13A PDS5A ROCK1 PHF14 ATM PCM1 HELLS | 2.07e-07 | 1257 | 141 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.81e-07 | 146 | 141 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | AHI1 ATAD5 CEP290 KIAA0586 DACH1 UBAP1 MSH3 GIT2 HUWE1 ANKHD1 KIF20B RIF1 PPIG ODF2L NEMF VPS13A PDS5A PHF14 PCM1 MAP3K19 | 6.26e-07 | 831 | 141 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR AHI1 ATAD5 NSD2 CEP290 KIAA0586 DACH1 CEP192 EFCAB14 HMMR RFC1 ATAD2 KIF20B ESCO2 ORC1 LIG4 RIF1 PPIG ODF2L NEMF VPS13A PDS5A ROCK1 PHF14 ATM PCM1 HELLS | 1.04e-06 | 1459 | 141 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR ATAD5 CEP290 DNM1L EFCAB14 KIF20B RIF1 PPIG SNCAIP ZFHX4 YLPM1 ROCK1 PCM1 MAP3K19 | 1.17e-06 | 432 | 141 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TET2 TPR ATAD5 CEP290 CEP192 EFCAB14 HMMR RFC1 ATAD2 KIF20B ESCO2 ORC1 RIF1 PPIG SNCAIP GVINP1 P2RY1 YLPM1 VPS13A ZNF638 ROCK1 PHF14 ATM PCM1 | 2.49e-06 | 1252 | 141 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | SLC9A9 ATAD5 NSD2 AAK1 HMMR TTC3 ATAD2 KIF20B ESCO2 LIG4 CBX5 UTRN HELLS | 4.97e-06 | 422 | 141 | 13 | GSM476658_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.61e-06 | 192 | 141 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NSD2 CEP290 KIAA0586 HMMR HUWE1 RFC1 JMJD1C DMXL1 ESCO2 ACE2 RIF1 ALKBH8 ZFHX4 CBX5 ROCK1 UTRN STAG3 HELLS | 6.54e-06 | 804 | 141 | 18 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | AHI1 ATAD5 CEP290 KIAA0586 DACH1 MANEA ANKHD1 KIF20B ORC1 RIF1 PPIG ODF2L NEMF VPS13A SLITRK5 PDS5A ROCK1 PHF14 PCM1 MAP3K19 | 8.73e-06 | 989 | 141 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | AHI1 COBLL1 BLNK DACH1 LAMC2 MSH3 CCDC160 HUWE1 MYO5C LNPEP VPS13A QARS1 | 1.18e-05 | 390 | 141 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ATAD5 CEP290 CEP192 EFCAB14 KIF20B DMXL1 DHX9 RIF1 NEMF ZNF638 TMF1 PDS5A ROCK1 | 1.53e-05 | 469 | 141 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 CEP290 KIAA0586 NAP1L4 DNM1L EFCAB14 KIF20B RIF1 PPIG ODF2L EPS15L1 LLGL1 YLPM1 PCM1 MAP3K19 | 1.96e-05 | 629 | 141 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR ATAD5 KIAA0586 NAP1L4 DNM1L EFCAB14 JMJD1C PPIG ODF2L EPS15L1 LLGL1 YLPM1 UTRN PCM1 | 2.43e-05 | 564 | 141 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TPR AHI1 CEP290 CEP192 USP37 KIF20B YLPM1 ZNF638 TMF1 ROCK1 PHF14 PCM1 MAP3K19 | 2.53e-05 | 492 | 141 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | SLC9A9 ATAD5 NSD2 AAK1 TBC1D22B HMMR TTC3 KIF20B ESCO2 LIG4 UTRN HELLS | 2.63e-05 | 423 | 141 | 12 | GSM476655_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR AHI1 ATAD5 NSD2 CEP290 KIAA0586 SPAG9 HMMR RFC1 USP37 TTC3 KIF20B ESCO2 FBXO16 ORC1 PPIG ODF2L LLGL1 VPS13A PHF14 ATM PCM1 HELLS | 3.49e-05 | 1370 | 141 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | CEP192 HMMR ATAD2 KIF20B ESCO2 ORC1 RIF1 SYCP1 ATM STAG3 HELLS | 5.67e-05 | 387 | 141 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | TPR SLC9A9 SPAG1 EPB41L4B MUC15 BLNK DACH1 LAMA3 LAMC2 ATAD2 C4orf54 LNPEP VPS13A TJP2 C2orf80 UTRN | 6.69e-05 | 784 | 141 | 16 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 7.23e-05 | 105 | 141 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR AHI1 ATAD5 NSD2 CEP290 KIAA0586 DACH1 CEP192 HMMR KIF20B ORC1 RIF1 PPIG ODF2L VPS13A PHF14 ATM PCM1 HELLS | 7.69e-05 | 1060 | 141 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | ATAD5 NSD2 HMMR ATAD2 KIF20B ESCO2 ORC1 LIG4 RIF1 CBX5 HELLS | 1.10e-04 | 417 | 141 | 11 | GSM399403_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | ATAD5 DACH1 HMMR TTC3 KIF20B ESCO2 P2RY1 CBX5 PYGL RAI14 HELLS | 1.25e-04 | 423 | 141 | 11 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TPR DLG5 EPB41L4B CEP290 CEP192 USP37 KIF20B SNCAIP ZFHX4 STARD9 YLPM1 ZNF638 TMF1 ROCK1 PHF14 MAP3K19 | 1.37e-04 | 834 | 141 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.73e-04 | 123 | 141 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.83e-04 | 79 | 141 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | CEP290 HUWE1 ANKHD1 JMJD1C DMXL1 ESCO2 RIF1 CBX5 VPS13A SYCP1 ROCK1 ATM UTRN STAG3 HELLS | 2.06e-04 | 776 | 141 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPR AHI1 ATAD5 CEP290 CEP192 EFCAB14 MSH3 ATAD2 KIF20B DHX9 LIG4 RIF1 PPIG NEMF RNF10 TMF1 ROCK1 PHF14 BBS12 PCM1 | 2.07e-04 | 1241 | 141 | 20 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 3.15e-04 | 395 | 141 | 10 | GSM538340_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 3.34e-04 | 398 | 141 | 10 | GSM538338_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.45e-04 | 259 | 141 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KIF27 CEP192 HUWE1 USP37 ATAD2 DMXL1 ESCO2 ORC1 RIF1 RABGAP1L VPS13A SYCP1 ATM STAG3 HELLS | 3.71e-04 | 820 | 141 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | NSD2 KIAA0586 CEP192 HMMR USP37 ATAD2 KIF20B ESCO2 ORC1 RIF1 VPS13A SYCP1 ATM STAG3 HELLS | 3.80e-04 | 822 | 141 | 15 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 4.12e-04 | 266 | 141 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 4.14e-04 | 409 | 141 | 10 | GSM399452_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 4.22e-04 | 410 | 141 | 10 | GSM538387_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 4.69e-04 | 148 | 141 | 6 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.17e-04 | 210 | 141 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 5.52e-04 | 349 | 141 | 9 | GSM476675_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | SLC9A9 AHI1 WIPF3 DACH1 C4orf54 ACE2 SNCAIP ZFHX4 RAI14 QARS1 | 6.22e-04 | 431 | 141 | 10 | gudmap_developingKidney_e13.5_podocyte cells_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | AHI1 KIAA0586 DACH1 NAP1L4 DNM1L EFCAB14 HMMR CRNKL1 PPIG ODF2L LLGL1 YLPM1 | 6.28e-04 | 595 | 141 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.82e-04 | 105 | 141 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | MON2 AHI1 NSD2 EFCAB14 MSH3 HUWE1 ATAD2 KIF20B FBXO16 RIF1 SNCAIP LNPEP NEMF QARS1 | 6.95e-04 | 779 | 141 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 7.79e-04 | 163 | 141 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TPR AHI1 CEP290 CEP192 RFC1 USP37 KIF20B ZFHX4 YLPM1 ZNF638 TMF1 ROCK1 PHF14 MTUS2 PCM1 MAP3K19 | 7.93e-04 | 978 | 141 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | AHI1 COBLL1 BLNK DACH1 DNM1L MSH3 CCDC160 HUWE1 ATAD2 MYO5C LNPEP VPS13A QARS1 UTRN | 8.47e-04 | 795 | 141 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.66e-04 | 298 | 141 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR ATAD5 CEP290 NAP1L4 DNM1L EFCAB14 KIF20B RIF1 PPIG SNCAIP ZFHX4 YLPM1 TJP2 ROCK1 PCM1 MAP3K19 | 8.92e-04 | 989 | 141 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TPR CACNA1D SLC9A9 AHI1 MUC15 DACH1 LAMA3 EFCAB14 MSH3 HUWE1 SNCAIP ZFHX4 LNPEP QARS1 | 9.66e-04 | 806 | 141 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 1.01e-03 | 380 | 141 | 9 | GSM538207_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | CACNA1D NSD2 COBLL1 WIPF3 BLNK KDM3B LAMC2 CCDC160 MYO5C DHX9 FBXO16 TEKT1 TTC39A C2orf80 | 1.05e-03 | 813 | 141 | 14 | gudmap_developingKidney_e11.5_ureteric bud_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NSD2 CEP290 KIAA0586 HMMR JMJD1C DMXL1 ESCO2 RIF1 ALKBH8 ZFHX4 CBX5 ROCK1 UTRN HELLS | 1.07e-03 | 815 | 141 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR AHI1 ATAD5 NSD2 CEP290 KIAA0586 DACH1 CEP192 HMMR KIF20B MYO5C ORC1 RIF1 PPIG ODF2L VPS13A PHF14 ATM PCM1 HELLS | 1.08e-03 | 1414 | 141 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 1.10e-03 | 385 | 141 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100 | 1.22e-03 | 70 | 141 | 4 | gudmap_developingGonad_e14.5_ ovary_100 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.98e-10 | 198 | 144 | 10 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-09 | 179 | 144 | 9 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-08 | 187 | 144 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 1.23e-08 | 190 | 144 | 9 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.54e-08 | 195 | 144 | 9 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-08 | 197 | 144 | 9 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.92e-08 | 200 | 144 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.92e-08 | 200 | 144 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.92e-08 | 200 | 144 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 174 | 144 | 8 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 176 | 144 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 182 | 144 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 182 | 144 | 8 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 182 | 144 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-07 | 184 | 144 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-07 | 185 | 144 | 8 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-07 | 185 | 144 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 144 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.01e-07 | 190 | 144 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-07 | 191 | 144 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 2.09e-07 | 191 | 144 | 8 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-07 | 193 | 144 | 8 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-07 | 194 | 144 | 8 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.36e-07 | 194 | 144 | 8 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-07 | 194 | 144 | 8 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.36e-07 | 194 | 144 | 8 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-07 | 194 | 144 | 8 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.36e-07 | 194 | 144 | 8 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-07 | 195 | 144 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 2.65e-07 | 197 | 144 | 8 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.65e-07 | 197 | 144 | 8 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.65e-07 | 197 | 144 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-07 | 197 | 144 | 8 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-07 | 197 | 144 | 8 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-07 | 197 | 144 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.65e-07 | 197 | 144 | 8 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.65e-07 | 197 | 144 | 8 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.65e-07 | 197 | 144 | 8 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.65e-07 | 197 | 144 | 8 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-07 | 197 | 144 | 8 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-07 | 198 | 144 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.86e-07 | 199 | 144 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.86e-07 | 199 | 144 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 2.86e-07 | 199 | 144 | 8 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.86e-07 | 199 | 144 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-07 | 199 | 144 | 8 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-07 | 199 | 144 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.97e-07 | 200 | 144 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | medial-Hematologic-Proliferating_NK/T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.97e-07 | 200 | 144 | 8 | ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.97e-07 | 200 | 144 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.97e-07 | 200 | 144 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.97e-07 | 200 | 144 | 8 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-NoSEP / Disease, condition lineage and cell class | 2.97e-07 | 200 | 144 | 8 | f70cc9198339eab7fbc68f5d9b75dfb28c9afc89 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.97e-07 | 200 | 144 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-07 | 200 | 144 | 8 | ce012d738cbec1afdd6af0e10e94b2b6c17b036e | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.97e-07 | 200 | 144 | 8 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 2.97e-07 | 200 | 144 | 8 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.97e-07 | 200 | 144 | 8 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Severe-T/NK_proliferative|World / Disease group and Cell class | 2.97e-07 | 200 | 144 | 8 | 128d82eb4d5760adf872212d8e8b5787a889969f | |
| ToppCell | medial-Hematologic-Proliferating_NK/T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.97e-07 | 200 | 144 | 8 | bfde42e00a9a6b858937de87cd19c9ed3677d954 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-SEP / Disease, condition lineage and cell class | 2.97e-07 | 200 | 144 | 8 | ae500c8b7c2162cadd31bf44ee9dc3271192cf17 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.97e-07 | 200 | 144 | 8 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | 2.97e-07 | 200 | 144 | 8 | d86119766b9c4f1570cd8045313345f9be46d431 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-07 | 200 | 144 | 8 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.97e-07 | 200 | 144 | 8 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | medial-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.97e-07 | 200 | 144 | 8 | 3d1895490dd262e9246eb280938239a7253451dd | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 165 | 144 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-06 | 169 | 144 | 7 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 169 | 144 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 169 | 144 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 169 | 144 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 169 | 144 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 171 | 144 | 7 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-06 | 172 | 144 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 180 | 144 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 180 | 144 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.26e-06 | 183 | 144 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.42e-06 | 185 | 144 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 187 | 144 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 187 | 144 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 187 | 144 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 2.70e-06 | 188 | 144 | 7 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.70e-06 | 188 | 144 | 7 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-06 | 190 | 144 | 7 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-06 | 190 | 144 | 7 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-06 | 191 | 144 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 191 | 144 | 7 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.10e-06 | 192 | 144 | 7 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 192 | 144 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.21e-06 | 193 | 144 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.21e-06 | 193 | 144 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-06 | 193 | 144 | 7 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.32e-06 | 194 | 144 | 7 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.43e-06 | 195 | 144 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 196 | 144 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.55e-06 | 196 | 144 | 7 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.33e-06 | 50 | 97 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of TPR | 1.85e-04 | 32 | 97 | 4 | GCM_TPR | |
| Drug | Clorgyline | MON2 MAP9 COBLL1 CEP290 MANEA DMXL1 LIG4 ODF2L VPS13A ZNF638 TMF1 PHF14 UTRN PCM1 RGPD5 | 1.69e-13 | 168 | 142 | 15 | ctd:D003010 |
| Drug | Succimer | TET2 ATAD5 ZNF185 SPAG9 HMMR USP37 TTC3 ATAD2 JMJD1C KIF20B DHX9 ESCO2 LIG4 RIF1 ALKBH8 SH3GLB1 ZFHX4 LNPEP STARD9 NEMF ZNF638 ROCK1 KIFC3 UTRN PCM1 HELLS | 6.89e-08 | 1264 | 142 | 26 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | TET2 ATAD5 ZNF185 SPAG9 HMMR USP37 TTC3 ATAD2 JMJD1C KIF20B DHX9 ESCO2 LIG4 RIF1 ALKBH8 SH3GLB1 ZFHX4 LNPEP STARD9 NEMF ZNF638 ROCK1 KIFC3 UTRN PCM1 HELLS | 1.39e-07 | 1310 | 142 | 26 | ctd:D058185 |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 3.82e-07 | 193 | 142 | 10 | 1412_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.12e-06 | 190 | 142 | 9 | 4306_DN | |
| Drug | Thimerosal | TET2 TPR MAP9 COBLL1 WIPF3 SPAG9 EFCAB14 GIT2 RFC1 KCNB2 JMJD1C DHX9 ESCO2 FSIP2 SNCAIP LNPEP CBX5 PYGL ATM PCM1 HELLS | 1.75e-05 | 1199 | 142 | 21 | ctd:D013849 |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.78e-05 | 180 | 142 | 8 | 2859_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.73e-05 | 191 | 142 | 8 | 6020_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.05e-05 | 194 | 142 | 8 | 4599_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.05e-05 | 194 | 142 | 8 | 1856_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 3.05e-05 | 194 | 142 | 8 | 1264_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.16e-05 | 195 | 142 | 8 | 5313_UP | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | 3.16e-05 | 195 | 142 | 8 | 1108_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 3353_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 7425_UP | |
| Drug | tricarballylate | 3.36e-05 | 59 | 142 | 5 | CID000014925 | |
| Drug | Demecolcine | ASXL1 SLC9A9 NACA ANKHD1 NREP ATAD2 JMJD1C ESCO2 ORC1 RIF1 CBX5 VPS13A ZNF638 TMF1 ALPK2 PCM1 HELLS | 3.47e-05 | 878 | 142 | 17 | ctd:D003703 |
| Drug | titanium nitride | 3.78e-05 | 11 | 142 | 3 | CID000093091 | |
| Drug | Ap4U | 5.01e-05 | 12 | 142 | 3 | CID000165888 | |
| Disease | Junctional epidermolysis bullosa | 6.59e-05 | 3 | 139 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 6.59e-05 | 3 | 139 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 6.59e-05 | 3 | 139 | 2 | 226700 | |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 1.31e-04 | 4 | 139 | 2 | C1301365 | |
| Disease | Herlitz Disease | 1.31e-04 | 4 | 139 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.31e-04 | 4 | 139 | 2 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.18e-04 | 5 | 139 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.18e-04 | 5 | 139 | 2 | C2608084 | |
| Disease | Myelodysplastic syndrome | 2.18e-04 | 5 | 139 | 2 | cv:C3463824 | |
| Disease | JOUBERT SYNDROME 17 | 2.18e-04 | 5 | 139 | 2 | C3553264 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.18e-04 | 5 | 139 | 2 | 614286 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 2.18e-04 | 5 | 139 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.18e-04 | 5 | 139 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Microcephaly | 2.87e-04 | 67 | 139 | 4 | C0025958 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.07e-04 | 28 | 139 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | fasting blood insulin measurement | 3.22e-04 | 69 | 139 | 4 | EFO_0004466 | |
| Disease | Junctional Epidermolysis Bullosa | 3.26e-04 | 6 | 139 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 4.56e-04 | 7 | 139 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Sclerocystic Ovaries | 6.15e-04 | 144 | 139 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 6.15e-04 | 144 | 139 | 5 | C0032460 | |
| Disease | Peripheral T-Cell Lymphoma | 9.67e-04 | 10 | 139 | 2 | C0079774 | |
| Disease | alkaline phosphatase measurement | TET2 DLG5 UBAP1 JMJD1C LLGL1 ZNF45 RNF10 TEKT1 PYGL RAI14 PLEKHH2 UTRN ALPK2 | 1.05e-03 | 1015 | 139 | 13 | EFO_0004533 |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.22e-03 | 15 | 139 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Polydactyly | 2.32e-03 | 117 | 139 | 4 | C0152427 | |
| Disease | body weight | TET2 EPB41L4B ATAD5 RGPD1 AAK1 CEP192 HUWE1 KCNB2 NREP ODF2L RABGAP1L ZNF638 UNC79 PCM1 | 2.57e-03 | 1261 | 139 | 14 | EFO_0004338 |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 2.86e-03 | 17 | 139 | 2 | C2936862 | |
| Disease | Bardet-Biedl syndrome | 3.21e-03 | 18 | 139 | 2 | cv:C0752166 | |
| Disease | hemoglobin A1 measurement | 3.32e-03 | 520 | 139 | 8 | EFO_0007629 | |
| Disease | Chronic myeloproliferative disorder | 3.57e-03 | 19 | 139 | 2 | C1292778 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.57e-03 | 19 | 139 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.57e-03 | 19 | 139 | 2 | C2936783 | |
| Disease | Familial aplasia of the vermis | 3.96e-03 | 20 | 139 | 2 | cv:C0431399 | |
| Disease | Fetal Growth Retardation | 3.96e-03 | 20 | 139 | 2 | C0015934 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.30e-03 | 139 | 139 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Joubert syndrome 1 | 4.36e-03 | 21 | 139 | 2 | C4551568 | |
| Disease | BREAST CANCER | 4.36e-03 | 21 | 139 | 2 | 114480 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 4.36e-03 | 21 | 139 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Cleft palate | 4.63e-03 | 71 | 139 | 3 | HP_0000175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQLKASTQKAANLSE | 621 | Q96QE3 | |
| KSLKSTQDEINQARS | 531 | Q9UBC2 | |
| ANSKTEAKQQAALSA | 161 | Q8NCV1 | |
| NKNATSISAKEANAT | 161 | Q0P641 | |
| ESNKRKSNFSNSADD | 86 | P45973 | |
| QSETKNLKATRNESF | 656 | Q96M83 | |
| NRSQLDINNKKSVTD | 246 | O00429 | |
| LQAAAAEASLNKSKS | 656 | Q2M2I8 | |
| DVSAANTNNLKKSTR | 81 | Q8N157 | |
| DTDNQNSQKSLKHRR | 161 | Q96BT7 | |
| QNKVSDLCSSNDKTL | 846 | Q86TB3 | |
| NLSKVNQKAAESLAD | 776 | P35606 | |
| SKRQANELISFKNQS | 1836 | Q7Z2Y8 | |
| SKQASLSDSNVEALK | 346 | Q8WYK0 | |
| TASKTNRQKSLDSDL | 406 | Q14161 | |
| TVDRQKSSLSNNSLK | 1171 | Q9ULJ7 | |
| RKISQAKDDSQNAID | 1181 | Q6PL18 | |
| NASESKLELRNNSNT | 1231 | Q6PL18 | |
| SKLNSRIFNSDISNK | 641 | Q6ZW61 | |
| KQAASTDSLRVLNDS | 711 | Q9UI36 | |
| NLTNNFKRNASSKER | 291 | Q9Y485 | |
| NNILESKFKSRASNA | 846 | Q53SF7 | |
| DSSNSQVSKLREKLQ | 361 | O75071 | |
| RQENLKTKALVSNSS | 881 | Q8IXJ9 | |
| ADLKKASSSNAAKSN | 816 | Q5JR59 | |
| ENSSDLSQKLKETQS | 476 | Q9P0K7 | |
| NDSLRKTQINSLKNS | 241 | Q5RL73 | |
| QSEKANTLKANRFSQ | 166 | Q9ULJ1 | |
| NNQSKSANSTLRLLS | 851 | Q29RF7 | |
| NSDIEQSSDSKVKNL | 1606 | Q99666 | |
| NSDIEQSSDSKVKNL | 1606 | O14715 | |
| QRSASQSSLDKLDQE | 726 | O60271 | |
| KRAANASSKLQEANA | 676 | Q15334 | |
| ENLQKTASKSANKRS | 211 | P20585 | |
| EAAKNASNTEKLTDQ | 16 | Q99733 | |
| VNRKKNDETNAASLT | 36 | Q16612 | |
| KASRRSEANLQSKSE | 341 | P47900 | |
| NKDSNSIIKDRLSET | 176 | Q9NRZ9 | |
| KKSTNNRASSASARL | 361 | Q49MG5 | |
| AKTLSSNSDKLLNEA | 2216 | Q16787 | |
| ALTDADNSVNKLTNK | 2331 | Q16787 | |
| NSDKENITTSNLKAS | 56 | Q8N387 | |
| RSIQKLASKEESSNS | 791 | O60524 | |
| KQRFSEENSKTDQNL | 266 | Q9NQ38 | |
| LDSAKLSSDQNDKAA | 286 | Q03252 | |
| ASTSAKNDLDLNRSQ | 971 | Q15652 | |
| QRAGKNKSSLESDEA | 866 | Q5CZC0 | |
| NKKLRSSQALNTDSL | 971 | Q86VH2 | |
| SVEKSTSSNRKNQLD | 1231 | Q15154 | |
| EAASSLKSQAATKNL | 576 | O96028 | |
| KNRDASTLQSQKAEG | 71 | O00479 | |
| KEELSASSARTQNLK | 1261 | Q96Q89 | |
| KDDNSATKTLSAAAR | 1671 | Q8TDM6 | |
| SAQEAQKDTDLSKNL | 511 | Q7LBC6 | |
| KSSLNGDNFRTQKLS | 911 | Q9UIQ6 | |
| SKNNEVSLAALKSFQ | 1156 | Q7Z3U7 | |
| SKSASSKNKSEQDAQ | 2266 | Q7Z6Z7 | |
| SKSNEDSLILEKSQN | 296 | O94880 | |
| SSSDELNKKFQSQRL | 381 | Q8IVE3 | |
| FQKSDRINSETNTKN | 61 | Q5SRI9 | |
| SQLSTRLEKQQAASK | 116 | B7ZAP0 | |
| SKSRDHNSSNNSREK | 666 | Q13427 | |
| HNSSNNSREKKADRD | 671 | Q13427 | |
| NNKASSSKATFQLEL | 901 | Q13349 | |
| KRQNKELSSSNSSLS | 321 | O43182 | |
| AALREKTSLSANNAT | 121 | O75330 | |
| RDAKEAKAQNEATST | 361 | Q13415 | |
| QDKRSNLESSQKSDL | 466 | Q13315 | |
| LAKEAAASNTNTLNR | 406 | Q8WXS5 | |
| QKDTLGNAVDKNTSR | 11 | Q9BZJ0 | |
| AQSSASLNSTRDKNL | 1736 | Q5TZA2 | |
| RKALSETSSNKSFEN | 496 | Q92953 | |
| LIDSQNNTKDSTRLK | 436 | Q8WV28 | |
| LLDSIASNNSAKRKD | 151 | P49917 | |
| KTSKNRENSLTDNLN | 1806 | O15078 | |
| QSQNSADRNVSKDTK | 3131 | Q8N3K9 | |
| ENKRNISKNETDTNS | 81 | A6NGH7 | |
| QQNGSSVLSEDKSKR | 101 | Q9BYF1 | |
| NTNTRDTSKKTKDQL | 361 | Q56NI9 | |
| LTNSSASCESKNKND | 231 | Q9UH90 | |
| VESQRLSNALSKQSA | 106 | Q8TEP8 | |
| QKVSDASDKTQQAER | 981 | Q13753 | |
| SKSKNFETLERASSQ | 146 | Q3LI81 | |
| LANLTTNDARDNSKD | 31 | Q9BZP3 | |
| TNDARDNSKDFQNSK | 36 | Q9BZP3 | |
| NQDALSSNTSLKLRK | 111 | Q8N4V1 | |
| LSAFRSSSSLRKKNN | 196 | Q8IX29 | |
| VTNRKSGSNLEKSNS | 1451 | D6RIA3 | |
| NINKKSSLQDASVRS | 636 | Q9H329 | |
| SFRNKNSDKQRSADS | 2046 | Q01668 | |
| EKQNTASLSKVNASR | 871 | Q56UN5 | |
| STNKKDAQSNAARDF | 51 | Q08211 | |
| NSDIEQSSDSKVKNL | 1591 | P0DJD0 | |
| SEQKARETLKNSALS | 16 | P47897 | |
| ASKKINSDSEELTQR | 606 | P46939 | |
| QKSRLSESQEKAANL | 1116 | P46939 | |
| LSDNATAFSNRSKQL | 91 | O75379 | |
| KVIKSSSDAQLSRNS | 126 | Q9NU19 | |
| RKEDSLTASQRKQSS | 26 | O75920 | |
| NNLSSDSKIRTKQLF | 351 | Q8IVB4 | |
| DSKARNLADDSSENK | 566 | P35251 | |
| SNSNNDERKKALISS | 1166 | Q5UIP0 | |
| SKTKQALSESQARNQ | 266 | Q9BVG8 | |
| ISKKRSSKNEDASNS | 251 | Q7Z4L9 | |
| AQASKNRSLADFEKA | 291 | O00231 | |
| KAKAAETRNSSEQEL | 181 | Q9Y371 | |
| AAKSNSKNSSIADLR | 266 | O15266 | |
| EFQDAQASSRNSKKI | 641 | Q9Y6H5 | |
| SSTNVEKADKQRNNS | 221 | Q969V4 | |
| SSDDIKGRNSQLSLK | 466 | A6NGB9 | |
| SLQAEDSNQKASSRL | 3376 | Q9P2P6 | |
| SKALQRQNSEGSASK | 361 | Q9UJM3 | |
| AANNNIKLLDKSDTA | 106 | P23515 | |
| SKQKSSSLQVADQDL | 751 | Q8IWZ3 | |
| LSFENQKRSSGLKNS | 141 | Q8N8J6 | |
| SFAKQALSQAQKSID | 11 | P82094 | |
| SERDNSEGKNSNKDS | 1121 | Q86UP3 | |
| SRDAKAQLALSSSAN | 6 | Q86VZ2 | |
| TSNKSSRKLFDQANK | 831 | Q9UDY2 | |
| SLSSGREEAKDSKQN | 2781 | Q96RL7 | |
| LDSDDSNQKTAKLAS | 271 | Q9NZ09 | |
| SKSDASQKQLSSLRD | 761 | Q9UJ98 | |
| RRKKNQSDHTSTNNS | 691 | O94991 | |
| QRLQEDTDKANKQSS | 466 | P12270 | |
| KSKEQEQSSLRASLE | 736 | Q15431 | |
| SFNNQSRRSSSQKSK | 76 | Q8N5U6 | |
| RAQLAKNAKTSSNGE | 181 | Q86VK4 | |
| ETNRSVKENSSQSKK | 21 | Q92670 | |
| NLLITADNSKDKESS | 1096 | Q6U841 | |
| RDLKNSEAASETQTK | 321 | Q07617 | |
| KNGVELSATRKNASN | 186 | Q9Y639 | |
| KQKSRNNESEKFSSS | 441 | P53804 | |
| RSKNKNSLSGLSIDE | 1871 | P53804 | |
| KDVKAAQSNENLSDS | 891 | P49750 | |
| TSSNADKSLQESLQK | 416 | Q13464 | |
| NTESSSKEKLDSNSN | 556 | Q8N9V7 | |
| DNQASAKRGSLETKD | 141 | Q86T82 | |
| KQLSLKQSEENRTSG | 246 | Q86T82 | |
| FNKIQDSSRNNSKTT | 761 | Q8NET8 | |
| AASLARLKNDNNKFT | 196 | Q8TCF1 | |
| AEKLSSLENSSNKNE | 1476 | Q6N021 | |
| SDLKISLSNESNKVN | 831 | P06737 | |
| AATLQAKSSLENSSR | 591 | Q5SRH9 | |
| ATQRDNSSGAKNLKE | 71 | Q02386 | |
| RKSNSTAAQEDAKAD | 386 | O15231 | |
| KRDDSNNKTLAEQNT | 1501 | Q14966 | |
| LNNNDSLTRKSESSN | 371 | Q9BVV6 | |
| SRTGKKENQDASNLT | 51 | Q9P2D8 | |
| SRAKAVRALKNNSND | 191 | Q9H009 | |
| SRAKAVRALKNNSND | 191 | Q13765 | |
| NAKTTRNDNSSRFGK | 206 | Q9NQX4 |